Takeda Pharmaceutical (TAK) Liabilities from Discontinued Operations (2018 - 2026)

Takeda Pharmaceutical's Liabilities from Discontinued Operations history runs 8 years deep, the most recent figure standing at 5216017.89 for Q1 2026.

• In Q1 2026, Liabilities from Discontinued Operations changed N/A year-over-year to 5216017.89; the TTM figure through Mar 2026 stood at 5216017.89 (changed N/A YoY), while the FY2026 annual figure was 5434125.06, changed N/A from the prior year.
• Liabilities from Discontinued Operations was 5216017.89 for Q1 2026 at Takeda Pharmaceutical, up from 5094354.11 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 9514418.08 in Q1 2024 to a low of 1088635.11 in Q1 2023.
• Historically, Liabilities from Discontinued Operations has averaged 6134354.12 across 5 years, with a median of 5460781.27 in 2022.
• Biggest YoY gain for Liabilities from Discontinued Operations was 773.98% in 2024; the steepest drop was 773.98% in 2024.
• A 5-year view of Liabilities from Discontinued Operations shows it stood at 8302867.7 in 2022, then tumbled by 86.89% to 1088635.11 in 2023, then jumped by 745.6% to 9205448.04 in 2024, then tumbled by 44.66% to 5094354.11 in 2025, then climbed by 2.39% to 5216017.89 in 2026.
• The last three Liabilities from Discontinued Operations figures came in at 5216017.89 (Q1 2026), 5094354.11 (Q4 2025), and 4947547.39 (Q3 2025), per Business Quant data.